Clinical Trials Logo

Clinical Trial Summary

The study described here is being conducted to prospectively confirm the performance of the ExoDx Prostate gene expression assay in patients presenting for an initial prostate biopsy and support of CE-marking the test for a European Union Launch.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04720599
Study type Observational
Source Exosome Diagnostics, Inc.
Contact
Status Completed
Phase
Start date June 1, 2020
Completion date June 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06397287 - PROM Project Urology
Active, not recruiting NCT04840511 - The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping N/A
Not yet recruiting NCT06398314 - Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors N/A
Completed NCT04933604 - LPN in Patients With High-complex Renal Tumors
Recruiting NCT06187870 - Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies
Recruiting NCT05726136 - Fluid Challenge and Plasma Volume, During Surgery Phase 4
Not yet recruiting NCT03715855 - Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples N/A
Recruiting NCT04931979 - SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy Phase 2
Terminated NCT03721042 - Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples N/A
Recruiting NCT05913245 - Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy N/A
Completed NCT05072639 - Preoperative Guided Imagery in Patients Undergoing Urologic Surgery N/A
Active, not recruiting NCT05169437 - Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Phase 2
Completed NCT04213157 - Laparoscopic Partial Nephrectomy for cT1 Tumors
Not yet recruiting NCT06282354 - Telemedicine for Postoperative Follow-up After Oncological Surgeries
Recruiting NCT00294476 - IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma Phase 2
Completed NCT03602079 - Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Phase 1/Phase 2
Recruiting NCT05725304 - The Registry of Genetic Expression of Taiwan Urologic Cancer
Not yet recruiting NCT05920343 - VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy Phase 2/Phase 3
Completed NCT03245788 - Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study N/A
Recruiting NCT04702347 - Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study